These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 34252073)

  • 21. Longitudinal microbiome analysis of single donor fecal microbiota transplantation in patients with recurrent Clostridium difficile infection and/or ulcerative colitis.
    Mintz M; Khair S; Grewal S; LaComb JF; Park J; Channer B; Rajapakse R; Bucobo JC; Buscaglia JM; Monzur F; Chawla A; Yang J; Robertson CE; Frank DN; Li E
    PLoS One; 2018; 13(1):e0190997. PubMed ID: 29385143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effective fecal microbiota transplantation for recurrent Clostridioides difficile infection in humans is associated with increased signalling in the bile acid-farnesoid X receptor-fibroblast growth factor pathway.
    Monaghan T; Mullish BH; Patterson J; Wong GK; Marchesi JR; Xu H; Jilani T; Kao D
    Gut Microbes; 2019; 10(2):142-148. PubMed ID: 30183484
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metagenomic strain detection with SameStr: identification of a persisting core gut microbiota transferable by fecal transplantation.
    Podlesny D; Arze C; Dörner E; Verma S; Dutta S; Walter J; Fricke WF
    Microbiome; 2022 Mar; 10(1):53. PubMed ID: 35337386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in microbial ecology after fecal microbiota transplantation for recurrent C. difficile infection affected by underlying inflammatory bowel disease.
    Khanna S; Vazquez-Baeza Y; González A; Weiss S; Schmidt B; Muñiz-Pedrogo DA; Rainey JF; Kammer P; Nelson H; Sadowsky M; Khoruts A; Farrugia SL; Knight R; Pardi DS; Kashyap PC
    Microbiome; 2017 May; 5(1):55. PubMed ID: 28506317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alteration of gut microbial composition associated with the therapeutic efficacy of fecal microbiota transplantation in Clostridium difficile infection.
    Lee PC; Chang TE; Wang YP; Lee KC; Lin YT; Chiou JJ; Huang CW; Yang UC; Li FY; Huang HC; Wu CY; Huang YH; Hou MC
    J Formos Med Assoc; 2022 Sep; 121(9):1636-1646. PubMed ID: 34836663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transmission and clearance of potential procarcinogenic bacteria during fecal microbiota transplantation for recurrent Clostridioides difficile.
    Drewes JL; Corona A; Sanchez U; Fan Y; Hourigan SK; Weidner M; Sidhu SD; Simner PJ; Wang H; Timp W; Oliva-Hemker M; Sears CL
    JCI Insight; 2019 Oct; 4(19):. PubMed ID: 31578306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A microbial consortium alters intestinal
    Rooney AM; Cochrane K; Fedsin S; Yao S; Anwer S; Dehmiwal S; Hota S; Poutanen S; Allen-Vercoe E; Coburn B;
    mBio; 2023 Aug; 14(4):e0348222. PubMed ID: 37404011
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recovery of the gut microbiome following fecal microbiota transplantation.
    Seekatz AM; Aas J; Gessert CE; Rubin TA; Saman DM; Bakken JS; Young VB
    mBio; 2014 Jun; 5(3):e00893-14. PubMed ID: 24939885
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Colonization potential to reconstitute a microbe community in patients detected early after fecal microbe transplant for recurrent C. difficile.
    Kumar R; Maynard CL; Eipers P; Goldsmith KT; Ptacek T; Grubbs JA; Dixon P; Howard D; Crossman DK; Crowley MR; Benjamin WH; Lefkowitz EJ; Weaver CT; Rodriguez JM; Morrow CD
    BMC Microbiol; 2016 Jan; 16():5. PubMed ID: 26758906
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The trans-kingdom battle between donor and recipient gut microbiome influences fecal microbiota transplantation outcome.
    Kazemian N; Ramezankhani M; Sehgal A; Khalid FM; Kalkhoran AHZ; Narayan A; Wong GK; Kao D; Pakpour S
    Sci Rep; 2020 Oct; 10(1):18349. PubMed ID: 33110112
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of fecal microbiota transplantation for recurrent Clostridium difficile infection in children on kidney replacement therapy: a pilot study.
    Samaey A; Vázquez-Castellanos JF; Caenepeel C; Evenepoel P; Vermeire S; Raes J; Knops N
    Pediatr Nephrol; 2024 Apr; 39(4):1201-1212. PubMed ID: 37775582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microbial taxonomic and metabolic alterations during faecal microbiota transplantation to treat Clostridium difficile infection.
    Kellingray L; Gall GL; Defernez M; Beales ILP; Franslem-Elumogo N; Narbad A
    J Infect; 2018 Aug; 77(2):107-118. PubMed ID: 29746938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term durability and safety of fecal microbiota transplantation for recurrent or refractory Clostridioides difficile infection with or without antibiotic exposure.
    Lee CH; Chai J; Hammond K; Jeon SR; Patel Y; Goldeh C; Kim P
    Eur J Clin Microbiol Infect Dis; 2019 Sep; 38(9):1731-1735. PubMed ID: 31165961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alterations and Prediction of Functional Profiles of Gut Microbiota After Fecal Microbiota Transplantation for Iranian Recurrent
    Azimirad M; Jo Y; Kim MS; Jeong M; Shahrokh S; Asadzadeh Aghdaei H; Zali MR; Lee S; Yadegar A; Shin JH
    J Inflamm Res; 2022; 15():105-116. PubMed ID: 35023946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systems biology evaluation of refractory Clostridioides difficile infection including multiple failures of fecal microbiota transplantation.
    Gonzales-Luna AJ; Spinler JK; Oezguen N; Khan MAW; Danhof HA; Endres BT; Alam MJ; Begum K; Lancaster C; Costa GP; Savidge TC; Hurdle JG; Britton R; Garey KW
    Anaerobe; 2021 Aug; 70():102387. PubMed ID: 34044101
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Faecalibacterium prausnitzii increases following fecal microbiota transplantation in recurrent Clostridioides difficile infection.
    Björkqvist O; Rangel I; Serrander L; Magnusson C; Halfvarson J; Norén T; Bergman-Jungeström M
    PLoS One; 2021; 16(4):e0249861. PubMed ID: 33836037
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variability of strain engraftment and predictability of microbiome composition after fecal microbiota transplantation across different diseases.
    Ianiro G; Punčochář M; Karcher N; Porcari S; Armanini F; Asnicar F; Beghini F; Blanco-Míguez A; Cumbo F; Manghi P; Pinto F; Masucci L; Quaranta G; De Giorgi S; Sciumè GD; Bibbò S; Del Chierico F; Putignani L; Sanguinetti M; Gasbarrini A; Valles-Colomer M; Cammarota G; Segata N
    Nat Med; 2022 Sep; 28(9):1913-1923. PubMed ID: 36109637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional Restoration of Bacteriomes and Viromes by Fecal Microbiota Transplantation.
    Fujimoto K; Kimura Y; Allegretti JR; Yamamoto M; Zhang YZ; Katayama K; Tremmel G; Kawaguchi Y; Shimohigoshi M; Hayashi T; Uematsu M; Yamaguchi K; Furukawa Y; Akiyama Y; Yamaguchi R; Crowe SE; Ernst PB; Miyano S; Kiyono H; Imoto S; Uematsu S
    Gastroenterology; 2021 May; 160(6):2089-2102.e12. PubMed ID: 33577875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Superiority of Higher-Volume Fresh Feces Compared to Lower-Volume Frozen Feces in Fecal Microbiota Transplantation for Recurrent Clostridioides Difficile Colitis.
    Agarwal A; Maheshwari A; Verma S; Arrup D; Phillips L; Vinayek R; Nair P; Hagan M; Dutta S
    Dig Dis Sci; 2021 Jun; 66(6):2000-2004. PubMed ID: 32656604
    [TBL] [Abstract][Full Text] [Related]  

  • 40. One dog's waste is another dog's wealth: A pilot study of fecal microbiota transplantation in dogs with acute hemorrhagic diarrhea syndrome.
    Gal A; Barko PC; Biggs PJ; Gedye KR; Midwinter AC; Williams DA; Burchell RK; Pazzi P
    PLoS One; 2021; 16(4):e0250344. PubMed ID: 33872339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.